Written and maintained by CASRAI Editorial Board
Published · Last updated
On this page
Short answer
21 CFR Part 830 is the part of the US device regulations that defines what a unique device identifier (UDI) is, how one must be issued, and what a labeler must send to FDA’s Global Unique Device Identification Database (GUDID). It has five subparts, A to E. Part 830 sets the identifier and the database rules; where a label must carry a UDI is set elsewhere in the chapter, and Part 830 points back to those sections. This page is general regulatory information, not legal or medical advice. Regulation text checked against Cornell LII’s copy of the eCFR on 2026-11-03.
What 21 CFR Part 830 covers (Subparts A to E)
| Subpart | Sections | Subject | Who it mainly addresses |
|---|---|---|---|
| A | 830.3 | General provisions and definitions | Everyone reading the rule |
| B | 830.10 to 830.60 | Requirements for a UDI | Labelers and issuing agencies |
| C | 830.100 to 830.130 | FDA accreditation of an issuing agency | Organizations that issue UDIs |
| D | 830.200 to 830.220 | FDA as an issuing agency | Labelers using an FDA-operated system |
| E | 830.300 to 830.360 | Global Unique Device Identification Database | Labelers submitting device data |
Section 830.3 defines the terms the rest of the rule uses. A UDI is “an identifier that adequately identifies a device through its distribution and use”. It has a mandatory, fixed device identifier (DI) that identifies the specific version or model and the labeler, and a conditional, variable production identifier (PI) that can carry the lot or batch, serial number, expiration date or manufacture date. A labeler is any person who causes a label to be applied to a device with the intent that it be commercially distributed without any subsequent replacement or modification of the label; a person who replaces or modifies a label counts, while adding only a distributor’s name and contact details does not.
21 CFR 830 UDI requirements for labelers
What a UDI must be (830.20)
A UDI must be issued under a system operated by FDA or by an FDA-accredited issuing agency, must conform to ISO/IEC 15459-2, 15459-4 and 15459-6 (incorporated by reference at 830.10), and may use only characters from the invariant character set of ISO/IEC 646. In practice this is why a DI that looks like a barcode number but was not issued under an accredited system can be rejected from the database (see 830.300 below).
Where Part 830 hands off to other sections
Part 830 does not say which devices or label levels need a UDI. Its timing rule is tied to “the date the label of the device must bear a unique device identifier under 801.20”, its voluntary-submission rule refers to a UDI placed on a label voluntarily under 801.40, and its permanent-marking data element applies where 801.45 requires the UDI on the device itself. For how the labeling rule works and how a label is read, see FDA labeling requirements for medical devices (21 CFR Part 801), UDI labels and UDI-PI.
21 CFR 830.300: which devices and when FDA may reject data
The labeler of a device must provide the Subpart E information for each version or model required to bear a UDI (830.300(a)). A labeler that voluntarily puts a UDI on a label under 801.40 may also voluntarily submit data. Under 830.300(c), FDA may reject or remove device identification data where:
- the DI does not conform to 830.20;
- the device is neither manufactured in the United States nor in interstate commerce in the United States;
- FDA determines the product is not a device, or a combination product that includes a device constituent part;
- the device or combination product requires, but does not have, FDA premarket approval, licensure or clearance;
- FDA has banned the device under section 516 of the Federal Food, Drug, and Cosmetic Act; or
- FDA has suspended the accreditation of the issuing agency that operates the system the labeler used.
21 CFR 830 Subpart E: GUDID data, timing and records
Subpart E section map
830.300 devices subject to submission; 830.310 information required; 830.320 submission of UDI information; 830.330 times for submission; 830.340 voluntary submission of ancillary information; 830.350 correction of information; 830.360 records to be maintained by the labeler.
How submission works (830.320)
Each labeler must designate an individual as its point of contact with FDA on device identification, responsible for ensuring FDA receives all required information; that contact may authorize an issuing agency or another person to submit on the labeler’s behalf. Submission is electronic to the GUDID unless FDA has granted a waiver; a labeler with a waiver sends a letter containing the 830.310 information instead.
The 830.310 data elements and what a receiving lab or clinic can compare
For each version or model, 830.310 lists 14 device-level items plus labeler-level details (name, a phone number or email for the designated contact, and the name of each issuing agency used). The table shows the device-level items that are stated “as it appears on the label”, or otherwise correspond to something printed on or packed with the device, so that a receiving department can compare a delivered item with its public database record. It is a checklist of what the rule requires the record to say, not a statement about any particular product.
| 830.310(b) item | What the rule says is reported |
|---|---|
| (1) Device identifier | The DI portion of the UDI assigned to the version or model |
| (4) Brand name | The proprietary, trade or brand name as it appears on the label |
| (5) Version or model number | Any version or model number or similar reference on the label |
| (6) Sterile | A statement, if the device is labeled as sterile |
| (7) Natural rubber latex | A statement, if the device or its packaging is labeled as containing natural rubber latex that contacts humans |
| (8) MRI safety | Whether a patient may be safely exposed to MRI while using, or with implanted, the device |
| (9) Size | Where more than one size exists, the size with its unit of measure as it appears on the label |
| (10) Production identifiers | The type of production identifiers that appear on the label |
| (11) Premarket submission | The FDA premarket submission number, or a statement that FDA exempted the device from premarket notification |
| (12) FDA listing number | The listing number assigned to the device |
| (13) GMDN term or code | The Global Medical Device Nomenclature term or code |
| (14) Package count | The total number of individual devices in the package |
The remaining two device-level items are the previous DI when a new DI replaces one already reported (item 2) and, where 801.45 requires a permanent marking, a statement that the marked DI is identical to the reported one or the marked DI itself (item 3).
Timing (830.330)
The initial submission is due no later than the date the label must bear a UDI under 801.20. Updates are due whenever the information changes, no later than the date a device is first labeled with the changed information; if the changed information does not appear on the label, within 10 business days of the change.
Ancillary information and corrections (830.340 and 830.350)
Nothing beyond the 830.310 items may be submitted unless FDA permits specified ancillary information; FDA announces changes to permitted types on its UDI website at least 60 days before making them. If FDA believes submitted information is incorrect or potentially misleading, it may ask the labeler to correct it or explain why it is right, and the labeler must respond within 30 days of receipt; FDA may delete or correct the information if there is no response or it determines the information is incorrect or misleading.
Records (830.360)
A labeler must keep, and submit to FDA on specific request, records of all UDIs used for devices that must bear one and the version or model tied to each DI, for 3 years from the date the labeler stops marketing that version or model. Meeting this does not replace recordkeeping duties under any other FDA regulation. For the submission workflow itself, see UDI labeling and GUDID submission.
Part 830 vs Part 801 vs Part 821
| Part | What it governs | Where it appears in Part 830 |
|---|---|---|
| 830 | UDI definition, issuing, and GUDID data, timing and records | This page |
| 801 (801.20, 801.40, 801.45) | Whether a label or device must bear a UDI, voluntary UDIs, direct marking | Referenced in 830.300(b), 830.310(b)(3) and 830.330(a) |
| 821 | Medical device tracking | Separate rule; see medical device tracking requirements |
Common misunderstandings
- The GUDID holds the whole UDI. FDA’s UDI Basics page states the GUDID contains the device identifier only, not the production identifier (page last updated 2022-08-17, checked 2026-11-03).
- Part 830 decides which products need a UDI. The label requirement sits in Part 801; Part 830 defines the identifier and the database submission.
- Any barcode number counts. 830.20 requires issuance under an FDA or FDA-accredited system and conformity to the named ISO/IEC standards.
- The database record replaces the label. The record is the labeler’s submission; 830.310 describes it as information about what appears on the label.
FAQ
What is 21 CFR 830?
It is the Unique Device Identification part of FDA’s device regulations, covering the UDI definition, the issuing system and the GUDID.
What are the 21 CFR 830 UDI requirements?
A UDI issued under an FDA or FDA-accredited system, conforming to the ISO/IEC standards in 830.20, plus submission of the 830.310 data to the GUDID on the 830.330 schedule and retention of UDI records for 3 years after the version or model leaves the market.
What does 21 CFR 830.300 say?
The labeler must submit data for each version or model that must bear a UDI, may submit voluntarily if it labels voluntarily under 801.40, and FDA may reject or remove data on the six grounds listed above.
What is 21 CFR 830 Subpart E?
Subpart E, 830.300 to 830.360, is the Global Unique Device Identification Database subpart: who submits, what, how, when, corrections and records.
Sources
- 21 CFR Part 830 and sections 830.3, 830.20, 830.300, 830.310, 830.320, 830.330, 830.340, 830.350, 830.360, as published by Cornell LII (law.cornell.edu/cfr/text/21/part-830), checked 2026-11-03. Official eCFR: ecfr.gov, Part 830.
- FDA, UDI Basics: fda.gov UDI Basics, page last updated 2022-08-17, checked 2026-11-03.







